67 results
8-K
EX-99.1
ALEC
Alector Inc
8 May 24
Alector Reports First Quarter 2024 Financial Results
4:10pm
. Forward-looking statements in this press release include, but are not limited to, statements regarding our business plans, business strategy, product
8-K
EX-99.1
ALEC
Alector Inc
27 Feb 24
Alector Reports Fourth Quarter and Full Year 2023 Financial Results
4:10pm
-Neurology Therapeutic Approach.” The publication discusses immuno-neurology as an emerging therapeutic strategy for dementia and neurodegeneration … by the Company’s strategy to prioritize late-stage programs.
G&A Expenses. Total general and administrative expenses for the quarter ended December 31
424B5
ocb zdu0bjiydyp
19 Jan 24
Prospectus supplement for primary offering
6:04am
424B5
marbw5f 3oke4lu6rlm
16 Jan 24
Prospectus supplement for primary offering
4:02pm
424B5
ledupysvdv crmca86
7 Nov 23
Prospectus supplement for primary offering
5:02pm
8-K
EX-99.1
59l0v7 xr
7 Nov 23
Alector Reports Third Quarter 2023 Financial Results and Provides Business Update
4:10pm
8-K
EX-99.1
dclynvl5fgc fyc1yb
3 Aug 23
Alector Reports Second Quarter 2023 Financial Results and Provides Business Update
4:11pm
8-K
EX-99.1
3o2 5flpwr83abeeg
4 May 23
Alector Reports First Quarter 2023 Financial Results and Provides Business Update
4:10pm
8-K
a7b enfxiva
29 Mar 23
Cost Associated with Exit or Disposal Activities
4:06pm
8-K
EX-99.1
aqv1fm8ph7d
8 Nov 22
Alector Reports Third Quarter 2022 Financial Results and Provides Business Update
4:10pm
8-K
EX-99.1
cw2z5vp10 x2dddbb
4 Aug 22
Alector Reports Second Quarter 2022 Financial Results and Provides Business Update
4:33pm